HIV vaccine trial halted after phase 3 failure

An HIV vaccine candidate failed to prove efficacy in a phase 3 trial, and it's now abandoned, according to Janssen, Johnson & Johnson's pharmaceutical arm. 

Read the full post at Becker's Hospital Review - Healthcare News